The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
How did the COVID crisis affect use of neoadjuvant therapy for patients with breast cancer?
 
Anees B. Chagpar
Leadership - Protean Biodiagnostics
Consulting or Advisory Role - Athenex; Genomic Health; Lumicell; Puma Biotechnology
 
Donald R. Lannin
No Relationships to Disclose
 
Sarah Schellhorn Mougalian
Stock and Other Ownership Interests - Coronado Biosciences; Gilead Sciences; Roche
Consulting or Advisory Role - Celgene; Eisai; Puma Biotechnology
Research Funding - Genentech; Pfizer
 
Elizabeth Rapp Berger
No Relationships to Disclose
 
Cary Philip Gross
Research Funding - AstraZeneca (Inst); Genentech; Johnson & Johnson (Inst); Pfizer (Inst)
(OPTIONAL) Uncompensated Relationships - Genentech (Inst)
 
Nina Ruth Horowitz
No Relationships to Disclose
 
Tara B. Sanft
No Relationships to Disclose
 
Michael DiGiovanna
Research Funding - Cascadian Therapeutics (Inst); Genentech (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - DAKO - Royalties; NeoMarkers - Royalties
 
Mehra Golshan
Consulting or Advisory Role - Abbvie
Research Funding - Breast Cancer Research Foundation
 
Lajos Pusztai
Consulting or Advisory Role - Almac Diagnostics; AstraZeneca; Athenex; Bristol Myers Squibb; Clovis Oncology; Eisai; H3 Biomedicine; Immunomedics; Merck; Novartis; Roche/Genentech; Seagen; Syndax
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca
(OPTIONAL) Uncompensated Relationships - Foundation Medicine; NanoString Technologies